Synthesis of ABT-378, an HIV Protease Inhibitor Candidate: Avoiding the Use of Carbodiimides in a Difficult Peptide Coupling
- 26 February 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 3 (2) , 145-148
- https://doi.org/10.1021/op980214p
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- HIV-1 Protease InhibitorsJAMA, 1997
- Section Reviews; Anti-infectives: Section Review Anti-infectives: HIV protease inhibitors in early developmentExpert Opinion on Investigational Drugs, 1996
- Ordered accumulation of mutations in HIV protease confers resistance to ritonavirNature Medicine, 1996
- Current Knowledge and Future Prospects for the Use of HIV Protease InhibitorsDrugs, 1996
- Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)AIDS, 1996
- A protection scheme for the preparation of acid chlorides of serine and threonineTetrahedron Letters, 1995
- An Efficient Stereocontrolled Strategy for the Synthesis of Hydroxyethylene Dipeptide IsosteresThe Journal of Organic Chemistry, 1994